Stay updated on JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page.

Latest updates to the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new study-record version submitted on 2026-11-02 was posted on 2026-11-03, with updates to study status and contacts/locations. The previously displayed date of 2026-09-28 is no longer shown.SummaryDifference0.3%

- Check18 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check25 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434, with both terms appearing during the transition.SummaryDifference0.4%

- Check32 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check39 days agoChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check46 days agoChange DetectedA new study-record version was submitted on 2026-09-25, documenting a study-status update; the page’s latest update date also advanced to 2026-09-28.SummaryDifference0.2%

Stay in the know with updates to JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page.